Table 1. Correlation between ZEB1-AS1 expression and clinicopathological features of UCB patients.
Characteristics | Group | Total | ZEB1-AS1 expression | P value | |
---|---|---|---|---|---|
High | Low | ||||
Gender | Male | 40 | 26 | 14 | 0.792 |
Female | 15 | 11 | 4 | ||
Age (years) | < 60 | 20 | 14 | 6 | 0.745 |
≥ 60 | 35 | 23 | 12 | ||
Tumor size (cm) | < 3 cm | 21 | 14 | 7 | 0.940 |
≥ 3 cm | 34 | 23 | 11 | ||
Multiplicity | Single | 33 | 20 | 13 | 0.197 |
Multiple | 22 | 17 | 5 | ||
Histological grade | Low | 23 | 10 | 13 | 0.001* |
High | 32 | 27 | 5 | ||
Tumor stage (T) | T1,T2 | 38 | 22 | 16 | 0.027* |
T3,T4 | 17 | 15 | 2 | ||
Lymph nodes metastasis | NO | 53 | 35 | 18 | 1.000 |
YES | 2 | 2 | 0 |
* P<0.05 was considered significant